93 related articles for article (PubMed ID: 28113084)
1. Increase of IRF-1 gene expression and impairment of T regulatory cells suppression activity on patients with myelodysplastic syndrome: A longitudinal one-year study.
Perazzio AS; Oliveira JS; Figueiredo VL; Chauffaille ML
Leuk Res; 2017 Apr; 55():6-17. PubMed ID: 28113084
[TBL] [Abstract][Full Text] [Related]
2. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes.
Bouchliou I; Miltiades P; Nakou E; Spanoudakis E; Goutzouvelidis A; Vakalopoulou S; Garypidou V; Kotoula V; Bourikas G; Tsatalas C; Kotsianidis I
Clin Immunol; 2011 Jun; 139(3):350-9. PubMed ID: 21444247
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).
Kordasti SY; Ingram W; Hayden J; Darling D; Barber L; Afzali B; Lombardi G; Wlodarski MW; Maciejewski JP; Farzaneh F; Mufti GJ
Blood; 2007 Aug; 110(3):847-50. PubMed ID: 17412885
[TBL] [Abstract][Full Text] [Related]
5. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
[TBL] [Abstract][Full Text] [Related]
6. Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide.
Buccione C; Fragale A; Polverino F; Ziccheddu G; Aricò E; Belardelli F; Proietti E; Battistini A; Moschella F
Int J Cancer; 2018 Mar; 142(5):976-987. PubMed ID: 28975621
[TBL] [Abstract][Full Text] [Related]
7. Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E.
Rathod SB; Das R; Thanapati S; Arankalle VA; Tripathy AS
J Viral Hepat; 2014 Feb; 21(2):141-51. PubMed ID: 24383927
[TBL] [Abstract][Full Text] [Related]
8. [Levels and Significance of Serum Interleukin-35 and the New Regulatory T Cells -iTR35 Cells in Myelodysplastic Syndrome Patients].
Xu WQ; Huang YM; Xiao HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):157-163. PubMed ID: 28245394
[TBL] [Abstract][Full Text] [Related]
9. An immune-modulating diet increases the regulatory T cells and reduces T helper 1 inflammatory response in Leishmaniosis affected dogs treated with standard therapy.
Cortese L; Annunziatella M; Palatucci AT; Lanzilli S; Rubino V; Di Cerbo A; Centenaro S; Guidetti G; Canello S; Terrazzano G
BMC Vet Res; 2015 Dec; 11():295. PubMed ID: 26634917
[TBL] [Abstract][Full Text] [Related]
10. Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells.
Maratheftis CI; Bolaraki PE; Giannouli S; Kapsogeorgou EK; Moutsopoulos HM; Voulgarelis M
Leuk Res; 2006 Sep; 30(9):1177-86. PubMed ID: 16483648
[TBL] [Abstract][Full Text] [Related]
11. An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss.
Lee SK; Kim JY; Hur SE; Kim CJ; Na BJ; Lee M; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2011 Nov; 26(11):2964-71. PubMed ID: 21926059
[TBL] [Abstract][Full Text] [Related]
12. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
Sturm N; Thélu MA; Camous X; Dimitrov G; Ramzan M; Dufeu-Duchesne T; Bonorino P; Guillermet C; Brambilla E; Arvers P; Pernollet M; Leroy V; Zarski JP; Marche PN; Jouvin-Marche E
J Hepatol; 2010 Jul; 53(1):25-35. PubMed ID: 20452085
[TBL] [Abstract][Full Text] [Related]
13. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.
Kotsianidis I; Nakou E; Bouchliou I; Tzouvelekis A; Spanoudakis E; Steiropoulos P; Sotiriou I; Aidinis V; Margaritis D; Tsatalas C; Bouros D
Am J Respir Crit Care Med; 2009 Jun; 179(12):1121-30. PubMed ID: 19342412
[TBL] [Abstract][Full Text] [Related]
14. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
[TBL] [Abstract][Full Text] [Related]
15. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
[TBL] [Abstract][Full Text] [Related]
16. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
Winger EE; Reed JL
Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
[TBL] [Abstract][Full Text] [Related]
17. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome.
Mailloux AW; Sugimori C; Komrokji RS; Yang L; Maciejewski JP; Sekeres MA; Paquette R; Loughran TP; List AF; Epling-Burnette PK
J Immunol; 2012 Sep; 189(6):3198-208. PubMed ID: 22875800
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
19. The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome.
Pinheiro RF; Metze K; Silva MR; Chauffaille Mde L
Leuk Res; 2009 Oct; 33(10):1308-12. PubMed ID: 19345417
[TBL] [Abstract][Full Text] [Related]
20. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
